Proterixbio

2 articles with Proterixbio

• ProterixBio announces commercial availability of a semi-quantitative COVID-19 antibody test

  9/29/2020

  ProterixBio, Inc. announced today commercial availability of the SARS-CoV-2 (RBD) IgG Antibody test, a semi-quantitative COVID-19 serology assay.

• ProterixBio licenses COVID-19 serology test from Massachusetts General Hospital

  7/1/2020

   ProterixBio, Inc. today announced completing a licensing agreement with the Massachusetts General Hospital for a COVID-19 serology assay. The assay was developed and validated by researchers at the Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University which is a joint vent